Direct Myosin Activation by Omecamtiv Mecarbil for Heart Failure with Reduced Ejection Fraction.

Psotka, Mitchell A

Direct Myosin Activation by Omecamtiv Mecarbil for Heart Failure with Reduced Ejection Fraction. [electronic resource] - Handbook of experimental pharmacology 2017 - 465-490 p. digital

Publication Type: Journal Article; Review

0171-2004

10.1007/164_2017_13 doi


Animals
Cardiac Myosins--metabolism
Cardiotonic Agents--therapeutic use
Clinical Trials as Topic
Disease Models, Animal
Heart Failure--drug therapy
Humans
Myocardial Contraction
Stroke Volume
Urea--analogs & derivatives